H. Hepp

Publications117
h-index16
Citations1,049
Highly Influential Citations34
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • D. Slamon
  • 436 Publications, 68,513 Citations
  • M. Untch
  • 661 Publications, 22,963 Citations
  • F. Jänicke
  • 196 Publications, 16,019 Citations
  • H. Graeff
  • 325 Publications, 8,209 Citations
  • Publications
  • Influence
Association between HER-2/neu and Vascular Endothelial Growth Factor Expression Predicts Clinical Outcome in Primary Breast Cancer Patients
Purpose: Activation or overexpression of HER-2/neu is associated with up-regulation of vascular endothelial growth factor (VEGF) in human breast cancer cells in vitro. Preclinical experiments… Expand
  • 215
  • 6
  • PDF
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
OBJECTIVE Our purpose was to: (a) study the in vitro chemosensitivity of primary epithelial ovarian cancer to drug combinations with cisplatin (CDDP), carboplatin (CBDCA), paclitaxel (PTX),… Expand
  • 98
  • 6
Pain intensity following laparoscopy.
The temperature of the gas used for insufflation during laparoscopy has a significant influence on postoperative shoulder and subphrenic pain according to a prospective randomized study of 103 female… Expand
  • 84
  • 4
Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.
PURPOSE Urokinase-type plasminogen activator (uPA) and its inhibitor, plasminogen activator inhibitor (PAI)-1, have been shown to be related to poor prognosis in a variety of malignant solid tumors.… Expand
  • 86
  • 3
  • PDF
Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.
PURPOSE Recent studies suggest that HER-2/neu specifically promotes the invasive capacity of tumor cells by up-regulating secretion of the proteolytic enzyme, urokinase-type plasminogen activator… Expand
  • 71
  • 3
Multifetal Gestation – Maternal and Perinatal Outcome of 112 Pregnancies
Purpose: Multifetal pregnancy reduction is a widespread ‘therapy’ to diminish the risk of prematurity and adverse outcome for the survivors in higher order multiple gestation. The aim of our study… Expand
  • 50
  • 2
  • PDF
HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer
Available clinical and experimental data on the effect of HER-2/neu overexpression on chemosensitivity are controversial. It was the purpose of this in vitro study to define the association between… Expand
  • 24
  • 2
[Prevalence and follow-up of hepatitis C virus infection in pregnancy].
Hepatitis C shows an increasing distribution in countries of western Europe. The aim of our study was to assess the prevalence of antibodies to hepatitis C (anti-HCV) in pregnancy, to evaluate the… Expand
  • 16
  • 2
Uterine dehiscence in a nullipara, diagnosed by MRI, following use of unipolar electrocautery during laparoscopic myomectomy: Case report.
Uterine scar dehiscence following laparoscopic myomectomy (LM) is a rare event. We present a case of an magnetic resonance imaging-diagnosed uterine dehiscence in a primigravid patient at 29 weeks… Expand
  • 57
  • 1
Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations.
In patients with PCOS low dose administration of follicle stimulating hormone is accepted as a safe treatment modality with low risk for an ovarian hyperstimulation syndrome or a multiple pregnancy.… Expand
  • 15
  • 1